Product Development Pipeline
The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day (see Product Showcase). There are over a thousand inventions from the Intramural Programs that are currently available for licensing to companies for commercial development (see Licensing Opportunities). Many inventions, however, have been licensed and are now in clinical development with the hope of eventually reaching the market. These are displayed in the Product Development Pipeline.
This information is updated periodically from information found at ClinicalTrials.gov, company websites, and other publicly-available resources.
Updated: November 2016